Vigabatrin use appears to be associated with visual field defects (VFDs) in paediatric patients with epilepsy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1556, 2006-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vigabatrin use appears to be associated with visual field defects (VFDs) in paediatric patients with epilepsy

By  

Reactions Weekly, Vol. 1, Iss. 1120, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Visual Field Defects and Other Ophthalmological Disturbances Associated with Vigabatrin

By Spence S.J.   Sankar R.  

Drug Safety, Vol. 24, Iss. 5, 2001-01 ,pp. : 385-404

Adis International

Access to resources Recommend Favorite

Visual Field Defects with Vigabatrin: Epidemiology and Therapeutic Implications

By Kälviäinen R.   Nousiainen I.  

CNS Drugs, Vol. 15, Iss. 3, 2001-01 ,pp. : 217-230

Adis International

Access to resources Recommend Favorite

Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study

By Wild John M.  

CNS Drugs, Vol. 23, Iss. 11, 2009-11 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Vigabatrin: guidelines for paediatric use revised

By  

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite